Full Committee Hearing: Johnson & Johnson's Recall of Children's Tylenol and other Children's Medicines and the Phantom Recall of Motrin (Part 2)
On Thursday, September 30, 2010, the Committee on Oversight and Government Reform held a hearing entitled, "Johnson & Johnson's Recall of Children's Tylenol and other Children's Medicines and the Phantom Recall of Motrin (Part 2)." This is the second hearing examining the circumstances surrounding the April 30, 2010, recall of more than 135 million bottles of Children's Tylenol and other popular pediatric medicines produced by Johnson & Johnson/McNeil Consumer Healthcare. The first hearing was held on May 27, 2010. This hearing will focus on both the broader recall announced in April of this year and on the "phantom recall" of an adult Motrin product that came to light as a result of the first hearing.
Witnesses
Panel I:
William C. Weldon
Chairman and Chief Executive Officer
Johnson & Johnson
Colleen Goggins
Worldwide Chairman, Consumer Group
Johnson & Johnson
Panel II:
Joshua M. Sharfstein, M.D.
Principal Deputy Commissioner
Food and Drug Administration (FDA)